• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative study of the efficacy and tolerability of hydroflumethiazide versus propranolol in Africans with mild to moderate hypertension.

作者信息

Ogola E N, Yonga G O

机构信息

Department of Medicine, College of Health Sciences, University of Nairobi, Kenya.

出版信息

East Afr Med J. 1993 May;70(5):277-9.

PMID:8306902
Abstract

Sixty patients with Diastolic Blood Pressure (DBP) of 100-110mmHg matched for age, sex and Bp levels were randomly assigned to propranolol 80mg daily or Hydroflumethiazide (HFM) 50mg daily. HFM causes a significant reduction in systolic blood pressure (SBP) and DBP within 4 weeks compared both with baseline and propranolol (SBP 143.7 +/- 12.3 vs 158.1 +/- 10.9mmHg, P < 0.05; DBP 92.0 +/- 4.5 vs 102.4 +/- 5.1mmHg, P < 0.05), (SBP 143.7 +/- 12.2 vs 152 +/- 11.0mmHg P < 0.05; DBP 92.0 +/- 4.5 vs 101.1 +/- 6.1mmHg, P < 0.05), respectively. Propranolol produced no significant difference from the baseline at 4 weeks (SBP 152.0 +/- H.0 vs 154.1 +/- 11.5mmHg NS; DBP 101.1 +/- 6.1 vs 102.2 +/- 5.6mmHg, NS). Reduction in BP by HFM was maintained after 8 and 12 weeks with further reduction but which did not achieve statistical significance. Increased dose of propranolol (160mg daily) after 4 weeks caused significant reduction in BP by 8 week (SBP 146.8 +/- 11.8 vs 152.0 +/- 11.0mmHg, P < 0.05; DBP 95.9 +/- 4.4 vs 101.1 +/- 6.1mmHg P < 0.05), which was maintained upto 12 weeks. The values however remained higher than in the HFM group. More patients in the HFM group achieved target BP (< 140/90), SBP 53.8% vs 29.6% P < 0.05, DBP 69.2% vs 14.8% P < 0.01. Incidence of side effects was similar and will be discussed. Thiazides are superior to B'blockers as initial monotherapy in black hypertensives.

摘要

相似文献

1
Comparative study of the efficacy and tolerability of hydroflumethiazide versus propranolol in Africans with mild to moderate hypertension.
East Afr Med J. 1993 May;70(5):277-9.
2
Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.普萘洛尔和氢氟噻嗪治疗肯尼亚轻度至中度原发性高血压患者的代谢效应。
East Afr Med J. 1993 Nov;70(11):696-700.
3
Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.根据基线收缩压评估比索洛尔单药治疗的疗效和耐受性：两项多中心、12 周、随机、双盲、安慰剂对照、平行分组、剂量范围研究的汇总数据的回顾性分析，这些研究纳入了轻至中度原发性高血压患者。
Clin Ther. 2009 Sep;31(9):1946-56. doi: 10.1016/j.clinthera.2009.08.028.
4
Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension.吲达帕胺与小剂量氢氯噻嗪单药治疗黑人轻至中度高血压患者的比较。
S Afr Med J. 2002 Jul;92(7):532-6.
5
A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).一项关于咪达普利和坎地沙坦对轻度至中度原发性高血压成年患者降压疗效及耐受性的为期12周的多中心、随机、双盲、平行组、非劣效性试验：伊比利亚多中心咪达普利高血压研究（IMISH）。
Clin Ther. 2006 Dec;28(12):2040-51. doi: 10.1016/j.clinthera.2006.12.006.
6
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.替米沙坦/氢氯噻嗪40/12.5毫克和80/12.5毫克固定剂量组合与氯沙坦/氢氯噻嗪50/12.5毫克固定剂量组合治疗轻度至中度原发性高血压的比较：两项多中心、前瞻性、随机、开放标签、盲终点（PROBE）试验的汇总分析
Clin Ther. 2005 Nov;27(11):1795-805. doi: 10.1016/j.clinthera.2005.11.014.
7
Randomised double-blind comparative study of efficacy and safety of hydroflumethiazide and reserpine and chlortalidone and atenolol in the treatment of mild to moderate hypertension in black patients.氢氟噻嗪与利血平、氯噻酮与阿替洛尔治疗黑人患者轻至中度高血压疗效与安全性的随机双盲对照研究。
J Hum Hypertens. 1993 Oct;7(5):447-50.
8
A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).通过动态血压监测评估厄贝沙坦和依那普利治疗轻至中度原发性高血压成人患者疗效和安全性的多中心、随机、双盲比较：MAPAVEL研究（动态血压监测APROVEL）
Clin Ther. 2002 Jan;24(1):126-38. doi: 10.1016/s0149-2918(02)85010-x.
9
Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.一项为期 8 周、多中心、随机、阳性药物对照、平行分组、评估坎地沙坦西酯氢氯噻嗪复方制剂治疗中国 II 期高血压患者的疗效和耐受性的 IV 期临床研究。
Clin Ther. 2011 Aug;33(8):1043-56. doi: 10.1016/j.clinthera.2011.07.002. Epub 2011 Aug 10.
10
A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.一项使用动态血压监测对轻度至中度高血压患者进行的替米沙坦和雷米普利的多中心、为期14周的研究。
Am J Hypertens. 2006 Jan;19(1):104-12. doi: 10.1016/j.amjhyper.2005.10.001.

引用本文的文献

1
Pharmacotherapy for hypertension in Sub-Saharan Africa: a systematic review and network meta-analysis.撒哈拉以南非洲地区高血压的药物治疗：系统评价和网络荟萃分析。
BMC Med. 2020 Mar 27;18(1):75. doi: 10.1186/s12916-020-01530-z.